Opioid receptor blockade reduces fas-induced hepatitis in mice

Hepatology

Volumn 40, Issue 5, 2004, Pages 1136-1143

  Jaume, Martial ^a   Jacquet, Sébastien ^a   Cavaillès, Pierre ^a   Macé, Gaëtane ^a   Stephan, Lionel ^a   Blanpied, Catherine ^a   Demur, Cécile ^a   Brousset, Pierre ^a   Dietrich, Gilles ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE IODIDE; FAS ANTIBODY; MESSENGER RNA; MORPHINE; NALTREXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRANULOCYTE; HEPATITIS; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ANIMALS; ANTIBODIES; ANTIGENS, CD95; CELLS, CULTURED; FEMALE; HEPATITIS; LIVER; MICE; MICE, INBRED BALB C; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, OPIOID; RNA, MESSENGER;

EID: 7044253647     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20428     Document Type: Article

References (40)

1. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
2. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997;3:409-413.
3. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 1998;4:588-593.
4. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
5. Higaki K, Yano H, Kojiro M. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 1996;149:429-437.
6. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9:347-351.
7. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 1991;261:G1051-G1056.
8. Li XK, Fujino M, Sugioka A, Morita M, Okuyama T, Guo L, et al. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers. Transplantation 2001;71:503-508.
9. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002;27:23-27.
10. Gujral JS, Farhood A, Bajt ML, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. HEPATOLOGY 2003;38:355-363.
11. Yin D, Mufson RA, Wang R, Shi Y. Fas-mediated cell death promoted by opioids. Nature 1999;397:218.
12. Yin D, Tuthill D, Mufson R, Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 2000;191:1423-1428.
13. Wang J, Charboneau R, Barke RA, Loh HH, Roy S. Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J Immunol 2002;169:3630-3636.
14. Grimm MC, Ben-Baruch A, Taub DD, Howard OMZ, Resau JH, Wang JM, et al. Opiates transdeactivate chemokine receptors: δ and μ opiate receptor-mediated heterologuous desensitization. J Exp Med 1998;188:317-325.
15. Sharp BM, Tsukayama DT, Gekker G, Keane WF, Peterson PK. Beta-endorphin stimulates human polymorphonuclear leukocyte superoxide production via a stereoselective opiate receptor. J Pharmacol Exp Ther 1987;242:579-582.
16. Di Francesco P, Tavazzi B, Gaziano R, Lazzarino G, Casalinuovo IA, Di Pierro D, et al. Differential effects of acute morphine administrations on polymorphonuclear cell metabolism in various mouse strains. Life Sci 1998;63:2167-2174.
17. Gavériaux-Ruff C, Matthes HWD, Peluso J, Kieffer BL. Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene. Proc Natl Acad Sci U S A 1998;95:6326-6330.
18. Singhal PC, Bhaskaran M, Patel J, Patel K, Kasinath BS, Duraisamy S, et al. Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 2002;168:4025-4033.
19. Van Loon GR, Appel NM, Ho D. Beta-Endorphin-induced stimulation of central sympathetic outflow: beta-endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats. Endocrinology 1981;109:46-53.
20. Yamauchi N, Shibasaki T, Wakabayashi I, Demura H. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat. Brain Res 1997;777:140-146.
21. Andre C, Couton D, Gaston J, Erraji L, Renia L, Varlet P, et al. beta2-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice. Am J Physiol 1999;276:G647-G654.
22. Evans-Storms RB, Cidlowski JA. Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB. Endocrinology 2000;141:1854-1862.
23. Bailly-Maitre B, de Sousa G, Zucchini N, Gugenheim J, Boulukos KE, et al. Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone. Cell Death Differ 2002;9:945-955.
24. Amsterdam A, Tajima K, Sasson R. Cell-specific regulation of apoprosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 2002;64:S43-S50.
25. Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, et al. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol 1994;113:1317-1327.
26. Collier TL, Schiller PW, Waterhouse RN. Radiosynthesis and in vivo evaluation of the pseudopeptide delta-opioid antagonist [(125)I]ITIPP(psi). Nucl Med Biol 2001;28:375-381.
27. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001;120:525-533.
28. Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A. Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin. J Pharm Pharmacol 2003;55:1013-1020.
29. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
30. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994;215:332-337.
31. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-49082.
32. Le'Negrate G, Selva E, Auberger P, Rossi B, Hofman P. Sustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cells. J Cell Biol 2000;150:1479-1488.
33. Chang B, Nishikawa M, Sato E, Inoue M. Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis. Arch Biochem Biophys 2003;411:63-72.
34. Welters ID, Menzebach A, Goumon Y, Langefeld TW, Teschemacher H, Hempelmann G, et al. Morphine suppresses complement receptor expression, phagocytosis, and respiratory butst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J Neuroimmunol 2000;111:139-145.
35. Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, Gibbons N. Morphine enhances macrophage apoptosis. J Immunol 1998;160:1886-1893.
36. Pasnik J, Tchorzewski H, Baj Z, Luciak M, Tchorzewski M. Priming effect of met-enkephalin and beta-endorphin on chemiluminescence, chemotaxis and CD11b molecule expression on human neutrophils in vitro. Immunol Lett 1999;67:77-83.
37. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. HEPATOLOGY 1998;27:1652-1660.
38. Matsuki Y, Li L, Hsu HC, Yang PA, Zheng R, Edwards CK 3rd, et al. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells. Cell Death Differ 2002;9:626-635.
39. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 1995;270:30290-30293.
40. Dobrenis K, Makman MH, Stefano GB. Occurrence of the opiate alkalioid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res 1995;686:239-248.